N-(2-(5-Chloro-2-methyl-1H-indol-3-yl)ethyl)-2-((4,6-dimethylpyridin-2-yl)amino)pyrimidine-5-carboxamide

ID: ALA4587876

PubChem CID: 155128754

Max Phase: Preclinical

Molecular Formula: C23H23ClN6O

Molecular Weight: 434.93

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)nc(Nc2ncc(C(=O)NCCc3c(C)[nH]c4ccc(Cl)cc34)cn2)c1

Standard InChI:  InChI=1S/C23H23ClN6O/c1-13-8-14(2)28-21(9-13)30-23-26-11-16(12-27-23)22(31)25-7-6-18-15(3)29-20-5-4-17(24)10-19(18)20/h4-5,8-12,29H,6-7H2,1-3H3,(H,25,31)(H,26,27,28,30)

Standard InChI Key:  OHRZKQWCWASXDO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    3.3766   -9.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7839  -10.3007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9881  -11.1006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1693   -9.9442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3764  -10.7418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7887  -11.3228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1596  -12.0614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9766  -11.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1105  -11.1214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5566  -12.5236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8322  -10.7108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5440  -11.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2610  -10.7198    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9729  -11.1367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6898  -10.7288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9676  -11.9617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3991  -11.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1157  -10.7419    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1213   -9.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4045   -9.4992    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6908   -9.9089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8378   -9.5071    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5502   -9.9232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5429  -10.7467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2544  -11.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9719  -10.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9734   -9.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2611   -9.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1722   -8.9241    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   12.2499  -11.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6884   -9.5129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
  1 29  1  0
 25 30  1  0
 27 31  1  0
M  END

Alternative Forms

  1. Alternative Forms:

    ALA4587876

    ---
  2. Parent:

    ALA4587876

    ---

Associated Targets(Human)

PTGER2 Tclin Prostanoid EP2 receptor (1730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR Tclin Prostanoid DP receptor (1356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER4 Tclin Prostanoid EP4 receptor (2181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

C6 (2371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.93Molecular Weight (Monoisotopic): 434.1622AlogP: 4.65#Rotatable Bonds: 6
Polar Surface Area: 95.59Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.71CX Basic pKa: 4.52CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.41Np Likeness Score: -1.52

References

1. Amaradhi R, Banik A, Mohammed S, Patro V, Rojas A, Wang W, Motati DR, Dingledine R, Ganesh T..  (2020)  Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models.,  63  (3): [PMID:31904232] [10.1021/acs.jmedchem.9b01218]

Source